Cite
Circulating Tumor Cells for the Staging of Patients With Newly Diagnosed Transplant-Eligible Multiple Myeloma.
MLA
Garcés, Juan-Jose, et al. “Circulating Tumor Cells for the Staging of Patients With Newly Diagnosed Transplant-Eligible Multiple Myeloma.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 40, no. 27, Sept. 2022, pp. 3151–61. EBSCOhost, https://doi.org/10.1200/JCO.21.01365.
APA
Garcés, J.-J., Cedena, M.-T., Puig, N., Burgos, L., Perez, J. J., Cordon, L., Flores-Montero, J., Sanoja-Flores, L., Calasanz, M.-J., Ortiol, A., Blanchard, M.-J., Rios, R., Martin, J., Martínez-Martinez, R., Bargay, J., Sureda, A., de la Rubia, J., Hernandez, M.-T., Rodriguez-Otero, P., … Paiva, B. (2022). Circulating Tumor Cells for the Staging of Patients With Newly Diagnosed Transplant-Eligible Multiple Myeloma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 40(27), 3151–3161. https://doi.org/10.1200/JCO.21.01365
Chicago
Garcés, Juan-Jose, Maria-Teresa Cedena, Noemi Puig, Leire Burgos, Jose J Perez, Lourdes Cordon, Juan Flores-Montero, et al. 2022. “Circulating Tumor Cells for the Staging of Patients With Newly Diagnosed Transplant-Eligible Multiple Myeloma.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 40 (27): 3151–61. doi:10.1200/JCO.21.01365.